Literature DB >> 11754390

The new World Health Organization classification of lymphomas: the past, the present and the future.

J K Chan1.   

Abstract

The REAL Classification of lymphomas, proposed in 1994, represents a new paradigm in lymphoma classification, consisting of a list of biologic entities defined by clinicopathologic and immunogenetic features. The non-Hodgkin's lymphomas comprise precursor lymphoblastic and mature cell neoplasms of B, T or putative natural killer cell lineage. An individual entity can exhibit a range of morphologic appearances and a range of clinical behavior. The categories in Hodgkin's lymphomas are identical to the widely used Rye classification except for the additional of a new category termed 'lymphocyte-rich classical Hodgkin's lymphoma'. The REAL classification has been validated by a major multi-institutional study involving 1378 cases (The Non-Hodgkin's Lymphoma Classification Project), showing that it is both reproducible and clinically relevant. The new World Health Organization classification of hematopoietic and lymphoid tumors, to be published in 2001, is a joint project of the Society for Hematopathology and European Association of Hematopathologists, under the auspices of the World Health Organization. This classification includes not only lymphoid neoplasms, but also myeloid, histiocytic and mast cell neoplasms. The lymphoma component of the classification is merely an update of the REAL classification, with minor changes necessitated by new information that has become available since its proposal. A conceptual grouping of the non-Hodgkin's lymphomas into four categories (indolent, aggressive, highly aggressive, and localized indolent) is also presented in this review. The next major impetus influencing the approach to lymphoma classification will no doubt be molecular genetics, in particular DNA microarrays, which will yield an enormous amount of new data that will aid in the understanding of lymphomas. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11754390     DOI: 10.1002/hon.660

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  35 in total

1.  Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.

Authors:  Linzhu Zhai; Yuanyuan Zhao; Sheng Ye; He Huang; Ying Tian; Qiuliang Wu; Hanliang Lin; Tongyu Lin
Journal:  Tumour Biol       Date:  2011-06-10

2.  Precursor T-cell lymphoblastic lymphoma extensively involving the mediastinum, pleura and pericardium: A case report.

Authors:  Xianhong Xiang; Xiaoyan Wang; Qinqin Yi; Lin Lin; Xiangsong Zhang; Hong Liang; Jianyong Yang
Journal:  Mol Clin Oncol       Date:  2014-07-11

3.  Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma.

Authors:  Toni Valković; Antica Duletić-Načinović; Sanja Stifter; Milena Hasan; Ita Hadžisejdić; David Zombori; Blaženka Grahovac; Nives Jonjić
Journal:  Clin Exp Med       Date:  2010-03-16       Impact factor: 3.984

4.  Expanded use of rituximab in the management of non-Hodgkin lymphoma.

Authors:  Dennis A Eichenauer; Andreas Engert; Holger Schulz
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

5.  Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors.

Authors:  Jiajia Huang; WenQi Jiang; Ruihua Xu; HuiQiang Huang; Yue Lv; ZhongJun Xia; XiaoFei Sun; ZhongZhen Guan; Tongyu Lin; ZhiMing Li
Journal:  BMC Cancer       Date:  2010-07-06       Impact factor: 4.430

6.  Three prognostic factors influence clinical outcomes of primary testicular lymphoma.

Authors:  Yu Wang; Zhi-Ming Li; Jia-Jia Huang; Yi Xia; Heng Li; Ya-Jun Li; Ying-Jie Zhu; Wei Zhao; Xi-Ya Xia; Wen-Xiao Wei; Hui-Qiang Huang; Tong-Yu Lin; Wen-Qi Jiang
Journal:  Tumour Biol       Date:  2012-09-11

7.  Clinical analysis of extranodal non-Hodgkin's lymphoma in the sinonasal tract.

Authors:  J-S Woo; J M Kim; S H Lee; S W Chae; S J Hwang; H-M Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-25       Impact factor: 2.503

8.  A polypoid mucosa-associated lymphoid tissue lymphoma of the stomach treated with endoscopic polypectomy.

Authors:  Shin Young Min; Jun Haeng Lee; Poong-Lyul Rhee
Journal:  Clin Endosc       Date:  2013-11-19

9.  Immunohistochemical (IHC) Analysis of Non-Hodgkin's Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India.

Authors:  Manisha Sharma; Rahul Mannan; Mohit Madhukar; Sanjay Navani; Mridu Manjari; Tejinder Singh Bhasin; Karamjit Singh Gill
Journal:  J Clin Diagn Res       Date:  2013-01-12

10.  Transcription factor expression in cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.

Authors:  Yoshinobu Matsuo; Hans G Drexler; Akira Harashima; Ayumi Okochi; Norio Shimizu; Kunzo Orita
Journal:  Hum Cell       Date:  2004-06       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.